Skip to content
Search AI Powered

Latest Stories

UK’s first keyhole breast reconstruction surgery marks major breakthrough

The procedure is a modified version of the DIEP flap surgery

UK’s first keyhole breast reconstruction surgery

Tanya Tanna , had her mastectomy in 2020

BBC

A woman from west London has become the first person in the UK to undergo a new form of breast reconstruction surgery using a keyhole technique, developed to aid quicker recovery and reduce complications following a mastectomy.

Tanya Tanna, 56, from South Ruislip, had the minimally invasive operation after her breast cancer diagnosis and subsequent mastectomy. The surgery was performed by a team of London-based surgeons and has been described as a significant breakthrough in cancer treatment.


The procedure is a modified version of the DIEP flap (deep inferior epigastric perforator) surgery, which is commonly used for breast reconstruction. It involves removing tissue, including a blood vessel, from the patient’s abdomen and using it to reconstruct the breast.

In standard DIEP flap operations, a large incision of around 10 to 12 centimetres is made in the abdominal wall. However, the new keyhole technique requires an incision of only 2 to 3 centimetres. According to the surgical team, this not only reduces trauma to the abdominal wall but also significantly lowers the risk of complications such as hernias and shortens the recovery time.

Ms Tanna described the experience as unexpectedly positive. “After this complex surgery, lasting eight hours, I was expecting a large amount of pain,” she said. “But I felt no pain, and the day afterwards I was up and about walking. The nurses were looking at me as if it was a miracle.”

The keyhole procedure was developed and carried out by Mr Dariush Nikkhah, a consultant plastic surgeon at the Royal Free Hospital, and Mr Alistair Slesser, a consultant colorectal surgeon at Hillingdon Hospital. The technique adapts a method being trialled in a small number of centres internationally, but has now been successfully introduced in the UK.

Mr Nikkhah said, “The Royal Free Hospital is now one of the few centres in the world which can offer this type of surgery. It is more challenging to perform, but it improves patient recovery. Instead of the usual four to seven-day hospital stay, patients undergoing this keyhole surgery may only need to remain in hospital for one to two days.”

Mr Slesser added, “This is a massive breakthrough in cancer surgery. We are continuing to refine the process and aim to develop a robotic-assisted version of the procedure.”

The robotic version would involve the surgeon operating instruments remotely via robotic arms, offering increased control and magnification during surgery. This, the team believes, could improve precision and reduce surgical risk even further.

Ms Tanna had her mastectomy in 2020, but her reconstructive surgery was delayed due to the COVID-19 pandemic and NHS backlogs. Mr Nikkhah later proposed the new keyhole option, and Ms Tanna agreed to become the first UK patient to undergo it.

“When I heard that I would be the first patient in the UK to have this procedure I was a bit nervous, but also excited,” she said. “The team promised to make me feel whole again, and that’s what they did.”

More For You

Zepbound Surpasses Wegovy in Groundbreaking Weight Loss Study

This may influence future decisions on treatment options for obesity patients

iStock

Eli Lilly's Zepbound outshines Wegovy in weight loss trial results

Eli Lilly announced on Sunday that its weight-loss drug, Zepbound, outperformed Novo Nordisk's Wegovy in a head-to-head trial, showing superior results across five weight-loss targets, including waist circumference reduction.

This trial, the first of its kind comparing the two widely used obesity medications, offers Eli Lilly a competitive advantage as it aims to secure broader insurance coverage in the rapidly growing obesity drug market, which is projected to exceed $150 billion annually by the next decade.

Keep ReadingShow less
Global Nursing Inequality Exposed in New Report on Nurses Day

The WHO forecasts a continued reduction in the global nursing shortage

iStock

International Nurses Day: Report shows the poorest regions face 70% shortages of nurses

The global nursing workforce has grown by nearly two million over the past five years, yet major disparities in distribution continue to impede progress towards universal health coverage (UHC) and global health goals, according to the State of the World’s Nursing 2025 report released on 12 May by the World Health Organization (WHO), International Council of Nurses (ICN), and partners.

As of 2023, there are 29.8 million nurses worldwide, up from 27.9 million in 2018. The report also notes a decline in the global nursing shortage, from 6.2 million in 2020 to 5.8 million in 2023. However, the report cautions that the improvements are not evenly shared across regions and income levels, leaving many low- and middle-income countries struggling with persistent shortfalls.

Keep ReadingShow less
Naga Munchetty’s IUD Experience Sparks Call for Better Women’s Healthcare

Munchetty has become an advocate against medical misogyny

Getty

Naga Munchetty passed out during an IUD fitting, says women deserve better treatment

BBC Breakfast presenter Naga Munchetty has spoken out about the severe pain she experienced during the fitting and removal of an intrauterine device (IUD), revealing she passed out twice during the procedure. She has called for greater transparency around the potential discomfort associated with the contraceptive and criticised what she describes as a culture of “medical misogyny”.

Speaking on the Life of Bryony podcast, Munchetty, 50, said she wanted more women to be fully informed about the realities of the procedure. She urged medical professionals to be honest about the potential for pain and to offer pain relief options, including anaesthetic, more readily.

Keep ReadingShow less
Ozempic

A dramatic shift in the weight-loss market

iStock

WeightWatchers seeks debt relief through US bankruptcy as Ozempic reshapes industry

WW, formerly WeightWatchers, has filed for bankruptcy in the United States as it faces mounting debt and major shifts in the health and wellness sector, particularly due to the rising popularity of Ozempic.

The company has entered Chapter 11 bankruptcy proceedings, allowing it to restructure around $1.15 billion (£860 million) in debt while continuing day-to-day operations. WW stressed there would be no disruption to its services, with workshops, digital tools, and telehealth support remaining fully accessible to members.

Keep ReadingShow less
Celebrities support Lepra’s prize draw for Mental Health Awareness Week

Celebrities support Lepra’s prize draw for Mental Health Awareness Week

Leading celebrities from across the UK including Sir Stephen Fry, Dame Helen Mirren, Dame Judi Dench, Miranda Hart, Dame Joanna Lumley and Olivia Colman, have all contributed items for Lepra’s first-ever Mental Health Awareness Week Prize Draw!

One lucky winner will receive a personalised video message from Olivia Colman. Also available to win are signed film and stage memorabilia from Dame Helen Mirren.

Keep ReadingShow less